- Patent Title: Panax plant extract and pharmaceutical composition and use thereof
-
Application No.: US16479221Application Date: 2017-12-04
-
Publication No.: US11541091B2Publication Date: 2023-01-03
- Inventor: Shangxian Gao
- Applicant: Shanghai Huiyu Biomedical Technology Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: Shanghai Huiyu Biomedical Technology Co., Ltd.
- Current Assignee: Shanghai Huiyu Biomedical Technology Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Bayramoglu Law Offices LLC
- Priority: CN201710054498.3 20170122
- International Application: PCT/CN2017/114497 WO 20171204
- International Announcement: WO2018/133563 WO 20180726
- Main IPC: A61K36/258
- IPC: A61K36/258 ; A61P25/28 ; A61P3/06 ; A61P3/10 ; A61P15/00 ; A61P35/00 ; A61K9/20 ; A61K31/7028

Abstract:
A Panax plant extract and a pharmaceutical composition and the use thereof. The mass ratio of Rk1 and Rg5 in the Panax plant extract is 1:1.0-1.5, and the content of Rg3, Rg5 and Rk1 in the extract is relatively high. The extract can be used to prepare a drug for treating chronic heart failure, coronary stable angina, arrhythmia, diabetes and complications thereof, Meniere's disease, hyperlipemia, fatty liver, Alzheimer's disease, dymenorrhea, metabolic syndrome, gout, tumours or vascular leak syndrome.
Public/Granted literature
- US20210177923A1 PANAX PLANT EXTRACT AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Public/Granted day:2021-06-17
Information query